Top Markets
Coin of the day
Orion Nutraceuticals Inc. Orion Nutraceuticals Inc.

Orion Nutraceuticals Inc.

ORI
Rank in Stocks #32989
Orion Nutraceuticals Inc., a company established in 2017 and headquartered in... Orion Nutraceuticals Inc., a company established in 2017 and headquartered in Vancouver, Canada, concentrates its efforts on developing pharmaceutical treatments for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) within the Canadian market. The firm previously operated under the name Cline Capital Corp.
Share Price
$0.29357476
Last synced: 2024-07-23
Market Cap
$8.60M
Change (1 day)
-0.91%
Change (1 year)
0.00%
Country
CA
Trade Orion Nutraceuticals Inc. (ORI)

Category

P/E ratio for Orion Nutraceuticals Inc. (ORI)
P/E ratio as of 2026 TTM: 0
According to Orion Nutraceuticals Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Orion Nutraceuticals Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.